Pharmacokinetics and pharmacodynamics of intravenous artesunate in severe falciparum malaria

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 1, 2001, Pages 181-186

  Davis, T M E ^a   Phuong, H L ^a   Ilett, K F ^a   Hung, N C ^a   Batty, K T ^a   Phuong, V D B ^a   Powell, S M ^a   Thien, H V ^a   Binh, T Q ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; DIHYDROARTEMISININ;

ADULT; ANTIMALARIAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG DISPOSITION; DRUG EFFECT; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALARIA FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ADULT; ANTIMALARIALS; AREA UNDER CURVE; ARTEMISININS; FEMALE; HALF-LIFE; HUMANS; INFUSIONS, INTRAVENOUS; MALARIA, FALCIPARUM; MALE; SESQUITERPENES;

EID: 0035172395     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.1.181-186.2001     Document Type: Article

References (41)

1. Artesunate. A review of its pharmacology and therapeutic efficacy in the treatment of malaria
2. Selective high-performance liquid chromatographic determination of artesunate and α- and β-dihydroartemisinin in patients with falciparum malaria
3. Chemical stability of artesunate injection and proposal for its administration by intravenous infusion
4. Assessment of the effect of malaria infection on hepatic clearance of dihydroartemisinin using rat liver perfusions and microsomes
5. A pharmacokinetic and pharmacodynamic study of intravenous versus oral artesunate in uncomplicated falciparum malaria
6. A pharmacokinetic and pharmacodynamic study of artesunate for vivax malaria
7. Pharmacokinetics of artemisinin and artesunate after oral administration in healthy volunteers
8. Pharmacokinetics of oral artesunate in children with moderately severe Plasmodium falciparum malaria
9. Fatal neurotoxicity of arteether and artemether
10. Artemether or artesunate followed by mefloquine as a possible treatment for multidrug resistant falciparum malaria
11. Differential effects of orally versus parenterally administered qinghaosu derivative artemether in dogs
12. Severe falciparum malaria with hyperparasitaemia treated with intravenous artesunate
13. Artesunate and cerebellar dysfunction in falciparum malaria
14. Quinine pharmacokinetics in cerebral malaria: Predicted plasma concentrations after rapid intravenous loading using a two-compartment model
15. Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria
16. Randomized controlled trial of artesunate plus tetracycline versus standard treatment (quinine plus tetracycline) for uncomplicated Plasmodium falciparum malaria in Brazil
17. Neurotoxicity of artemisinin: Possible counseling and treatment of side-effects
18. Efficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium falciparum malaria and in vitro susceptibility to artemisinin, chloroquine, and mefloquine
19. Comparison of artemisinin suppositories with intravenous artesunate and intravenous quinine in the treatment of cerebral malaria
20. An open randomized Comparison of intravenous and intramuscular artesunate in severe falciparum malaria
21. Qinghaosu
22. Artemisinin neurotoxicity: Neuropathology in rats and mechanistic studies in vitro
23. Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria
24. Comparative clinical trial of artesunate and the combination of artesunate-mefloquine in multidrug-resistant falciparum malaria
25. Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria
26. Comparative clinical trial of artesunate followed by mefloquine in the treatment of acute uncomplicated falciparum malaria: Two- and three-day regimens
27. Oral artesunate in the treatment of uncomplicated hyperparasitemic falciparum malaria
28. Single day mefloquine-artesunate combination in the treatment of multi-drug resistant falciparum malaria
29. Ataxia and slurred speech after artesunate treatment for falciparum malaria
30. Drug glucuronidation in humans
31. Glucuronidation and its role in regulation of biological activity of drugs
32. Post-malaria neurological syndrome
33. Artesunate versus artemether in combination with mefloquine for the treatment of multidrug-resistant falciparum malaria
34. Enhanced in vitro neurotoxicity of artemisinin derivatives in the presence of haemin
35. Non-compartmental analysis methods
36. Severe and complicated malaria (2nd edition)
37. Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives
38. Quinine pharmacokinetics and toxicity in cerebral and uncomplicated falciparum malaria
39. Clinical pharmacokinetics of a new effective antimalarial artesunate, a qinghaosu derivative
40. Studies on the phase 1 clinical pharmacokinetics of artesunate and artemether